Vertex Pharmaceuticals (VRTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Vertex Pharmaceuticals (VRTX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Vertex Pharmaceuticals

· VRTX

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

133.505 B

-0.74%

General

Market Cap: $133.51B
Enterprise Value: $128.53B
Shares Outstanding: 253,810,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 86.04%
Operating Margin: 38.59%
Net Profit Margin: 34.89%
FCF Margin: 30.07%
ROA: 16.06%
ROE: 23.31%
ROIC: 17.33%
Current Ratio: 3.19
Debt-to-Equity: 0.10
Revenue Per Employee: —

Valuation (TTM)

P/E: 30.13
PEG: 2.50
P/S: 10.51
P/FCF: 34.95
P/B: 6.55
EV/EBITDA: 23.61

Growth

Rev 1Y: 9.57%

Income Statement (TTM)

Revenue: $12.62B
Gross Margin: 86.04%
Operating Expenses: $5.99B
Operating Income: $4.87B
Net Profit: $4.41B

Balance Sheet

Rev 1Y Fwd Est

9.60%

Rev 3Y (CAGR)

10.58%

Rev 5Y (CAGR)

14.24%

Rev 10Y (CAGR)

27.88%

EPS 1Y

—

EPS 1Y Fwd Est

21.86%

EPS 3Y (CAGR)

6.12%

EPS 5Y (CAGR)

8.29%

EPS 10Y (CAGR)

—

Cash and Equivalents: $6.14B
Working Capital: $8.61B
Total Assets: $27.42B
Net Debt: -$4.17B
Total Liabilities: $7.18B
Total Equity: $20.25B

Cash Flow Statement (TTM)

Cash Flow from Operations: $4.29B
Cash Flow from Investing: -$882.8M
Cash Flow from Financing: -$2.2B
Free Cash Flow: $3.8B
Capital Expenditures: $496.8M